Register
Register
Register

Thursday, 22 May 2025 | 14:35 - 14:50

Single-Cell analysis during checkpoint immunotherapy reveals the tumor antigen landscape, advancing cancer vaccine development - Diether Lambrechts, KU Leuven

Recent advances in single-cell technologies shed light on the tumor antigen landscape of tumors and how they are translating these insights into mRNA-based cancer vaccines.

1 speaker

  • Diether Lambrechts

    Full Professor at KULeuven, Science Director at VIB Center for Cancer Biology

    KU Leuven